Patients must trust in a drug's safety for it to be marketed successfully. Drug withdrawals from the marketplace due to safety issues can shake the confidence of physicians and the general public. This makes the timely processing of safety data not only a regulatory requirement, but a strategic necessity. Outsourcing your post-marketing surveillance to Kendle will relieve your company of this critical task, freeing internal resources for other priorities.
We can assume total or partial responsibility for the process. Our team of global safety experts has local expertise and extensive experience in handling projects of all sizes, from large international projects to those involving just a few events per year. We’re also experts in signal detection methods, helping to identify the early warning signs of safety issues.
Let Kendle take the strain out of your post-marketing surveillance requirements.
Click here to download our post-marketing surveillance factsheet